KD Logo

Robert W. Baird upgrades Quest Diagnostics, Inc (DGX) rating to an Outperform

In a filing, Quest Diagnostics, Inc revealed its SVP, Corp. Controller & CAO DEPPE MICHAEL J unloaded Company’s shares for reported $2.89 million on Nov 06 ’24. In the deal valued at $154.05 per share,18,755 shares were sold. As a result of this transaction, DEPPE MICHAEL J now holds 34,941 shares worth roughly $5.6 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, KUPPUSAMY KARTHIK sold 1,775 shares, generating $278,525 in total proceeds. Upon selling the shares at $156.92, the SVP, Clinical Solutions now owns 9,734 shares.

Before that, KUPPUSAMY KARTHIK bought 1,775 shares. Quest Diagnostics, Inc shares valued at $278,450 were divested by the Officer at a price of $156.87 per share.

Robert W. Baird upgraded its Quest Diagnostics, Inc [DGX] rating to an Outperform from a a Neutral in a research note published on October 23, 2024; the price target was increased to $182 from $157. Citigroup also remained covering DGX and has increased its forecast on July 10, 2024 with a “Buy” recommendation from previously “Neutral” rating. Leerink Partners started covering the stock on February 26, 2024. It rated DGX as “a Market perform”.

Price Performance Review of DGX

On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock jump 0.50% to $160.17. Over the last five days, the stock has gained 3.78%. Quest Diagnostics, Inc shares have risen nearly 16.17% since the year began. Nevertheless, the stocks have risen 21.67% over the past one year. While a 52-week high of $160.95 was reached on 11/11/24, a 52-week low of $123.04 was recorded on 02/01/24. SMA at 50 days reached $153.60, while 200 days put it at $141.26.

Levels Of Support And Resistance For DGX Stock

The 24-hour chart illustrates a support level at 159.14, which if violated will result in even more drops to 158.11. On the upside, there is a resistance level at 161.84. A further resistance level may holdings at 163.50. The Relative Strength Index (RSI) on the 14-day chart is 66.67, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.34, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 22.13%. Stochastics %K at 75.87% indicates the stock is a holding.

How much short interest is there in Quest Diagnostics, Inc?

A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2024-10-15, dropping by 92630.0 shares to a total of 2.33 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.42 million shares. There was a decline of -3.98%, which implies that there is a negative sentiment for the stock.

Most Popular